Updates on the Immunopathology in Idiopathic Inflammatory Myopathies

Curr Rheumatol Rep. 2021 Jul 1;23(7):56. doi: 10.1007/s11926-021-01017-7.

Abstract

Purpose of review: To review recent advances in immunopathology for idiopathic inflammatory myopathies, focusing on widely available immunohistochemical analyses.

Recent findings: Sarcoplasmic expression of myxovirus resistance protein A (MxA) is specifically observed in all types of dermatomyositis and informs that type I interferons are crucially involved in its pathogenesis. It is a more sensitive diagnostic marker than perifascicular atrophy. Diffuse tiny dots in the sarcoplasm highlighted by p62 immunostaining are characteristically seen in immune-mediated necrotizing myopathy. This feature is linked to a chaperone-assisted selective autophagy pathway. Myofiber invasion by highly differentiated T cells, a marker of which is KLRG1, is specific to inclusion body myositis and has a crucial role in its pathogenesis. The recent advances in immunopathology contribute to increased diagnostic accuracy and a better understanding of the underlying pathophysiology in different types of idiopathic inflammatory myopathies.

Keywords: Immunohistochemistry; KLRG1; Membrane attack complex; Muscle pathology; MxA; p62.

Publication types

  • Review

MeSH terms

  • Autoimmune Diseases*
  • Biomarkers
  • Dermatomyositis*
  • Humans
  • Myositis*
  • Myositis, Inclusion Body*

Substances

  • Biomarkers